In-vitro and in-silico antibacterial and antibiofilm activities of an aromatic heterocyclic metabolite from a novel halo-thermophilic Streptomyces sp. strain CBN-1 against bacteria causing nosocomial infections
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10644-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von El-Hadj Driche und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Genomics and Bioinformatics (LBMGB), Department of Biology, Faculty of Nature and Life Sciences (NLS), Hassiba Benbo…. Hauptthemen laut MEDLINE: Streptomyces, Biofilms, Anti-Bacterial Agents, Cross Infection. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Multidrug-resistant and biofilm-forming pathogens have become a global health challenge, contributing to persistent and hard-to-treat infections. The objective of this study was to characterize an active metabolite produced by a novel halo-thermophilic Streptomyces sp. CBN-1 that exhibits potent antibacterial and antibiofilm activities using a combined in-silico and experimental approach. METHODS & RESULTS: In this study, a halo-thermophilic Streptomyces sp. CBN-1 strain was selected for its ability to grow in 10% NaCl at 40 °C. This strain was identified using phenotypic characterizations and 16S rRNA gene sequence analysis as Streptomyces rochei NRRL B-2410 with 99.15% similarity. An active metabolite, CBNa-1, was extracted using n-butanol solvent from ISP2 broth medium and purified by HPLC. Structural characterization using electrospray ionization mass spectrometry and NMR spectroscopy identified CBNa-1 as an aromatic heterocyclic compound regulated by non-ribosomal peptide synthetase (NRPS) and type II polyketide synthase (PKS) genes. It exhibited potent activity with minimum inhibitory concentrations (MIC) ranging from 4 to 5 µg/mL and minimum biofilm inhibitory concentrations (MBIC50%) at ½ MIC. Additionally, in-silico docking analyses showed that CBNa-1 had stronger binding affinities from - 8.7 to -8.1 kcal/mol with isoleucyl-tRNA synthetase, glucosamine-6-phosphate synthase, penicillin-binding protein 1a, type II DNA topoisomerases, and quorum sensing compared to antibiotics (-5.7 to -7.9 kcal/mol). Furthermore, molecular dynamic (MD) simulation showed the stability of the protein-ligand complex under physiological conditions. CONCLUSION: This study reports the first identification of CBNa-1, a metabolite from prokaryotic cells, with potent antibacterial and anti-biofilm properties to combat nosocomial infections caused by MDR pathogens, including bacteria resistant to third-generation cephalosporins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, Genomics and Bioinformatics (LBMGB), Department of Biology, Faculty of Nature and Life Sciences (NLS), Hassiba Benbouali University of Chlef, Ouled Fares, Chlef, 02180, Algeria. e.driche…
- Laboratory of Microbial Systems Biology (LMSB), Higher Normal School of Kouba, B.P. 92, Kouba, Alger, 16050, Algeria. e.driche@univ-chlef.dz.
- Laboratory of Microbial Systems Biology (LMSB), Higher Normal School of Kouba, B.P. 92, Kouba, Alger, 16050, Algeria.
- Proteomics Group, INSERM UMR1037, Cancer Research Center (CRCT) of Toulouse, Toulouse, France.
Zitieren
APA
Driche, E. H., Badji, B., Pont, F., & Zitouni, A. (2025). In-vitro and in-silico antibacterial and antibiofilm activities of an aromatic heterocyclic metabolite from a novel halo-thermophilic Streptomyces sp. strain CBN-1 against bacteria causing nosocomial infections. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10644-7
Vancouver
Driche EH, Badji B, Pont F, Zitouni A. In-vitro and in-silico antibacterial and antibiofilm activities of an aromatic heterocyclic metabolite from a novel halo-thermophilic Streptomyces sp. strain CBN-1 against bacteria causing nosocomial infections. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10644-7
BibTeX
@article{Driche2025,
author = {Driche, El-Hadj and Badji, Boubekeur and Pont, Frédéric and Zitouni, Abdelghani},
title = {In-vitro and in-silico antibacterial and antibiofilm activities of an aromatic heterocyclic metabolite from a novel halo-thermophilic Streptomyces sp. strain CBN-1 against bacteria causing nosocomial infections},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10644-7}
}
EUVIMED